181 related articles for article (PubMed ID: 9278190)
1. A two-process theory of schizophrenia: evidence from studies in post-mortem brain.
Deakin JF; Simpson MD
J Psychiatr Res; 1997; 31(2):277-95. PubMed ID: 9278190
[TBL] [Abstract][Full Text] [Related]
2. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
Deakin FW; Simpson MD; Slater P; Hellewell JS
J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
[TBL] [Abstract][Full Text] [Related]
3. The neuronal pathology of schizophrenia: molecules and mechanisms.
Reynolds GP; Harte MK
Biochem Soc Trans; 2007 Apr; 35(Pt 2):433-6. PubMed ID: 17371293
[TBL] [Abstract][Full Text] [Related]
4. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia.
Deakin JF; Slater P; Simpson MD; Gilchrist AC; Skan WJ; Royston MC; Reynolds GP; Cross AJ
J Neurochem; 1989 Jun; 52(6):1781-6. PubMed ID: 2566649
[TBL] [Abstract][Full Text] [Related]
5. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
Goldman-Rakic PS; Selemon LD
Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
[TBL] [Abstract][Full Text] [Related]
6. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
Gluck MR; Thomas RG; Davis KL; Haroutunian V
Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
[TBL] [Abstract][Full Text] [Related]
7. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome.
Gerlach M; Gsell W; Kornhuber J; Jellinger K; Krieger V; Pantucek F; Vock R; Riederer P
Brain Res; 1996 Nov; 741(1-2):142-52. PubMed ID: 9001716
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological implications of brain changes in schizophrenia: an overview.
Deakin JF
Psychopathology; 1994; 27(3-5):251-4. PubMed ID: 7846246
[TBL] [Abstract][Full Text] [Related]
9. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia.
Csernansky JG; Bardgett ME
Schizophr Bull; 1998; 24(2):231-48. PubMed ID: 9613623
[TBL] [Abstract][Full Text] [Related]
10. Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex.
Ohnuma T; Suzuki T; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):889-94. PubMed ID: 15949884
[TBL] [Abstract][Full Text] [Related]
11. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia and glutamatergic transmission.
Tamminga CA
Crit Rev Neurobiol; 1998; 12(1-2):21-36. PubMed ID: 9444480
[TBL] [Abstract][Full Text] [Related]
13. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?
Benes FM
Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640
[No Abstract] [Full Text] [Related]
14. [Schizophrenia and cortical GABA neurotransmission].
Hashimoto T; Matsubara T; Lewis DA
Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
[TBL] [Abstract][Full Text] [Related]
15. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.
Reynolds GP; Czudek C; Andrews HB
Biol Psychiatry; 1990 May; 27(9):1038-44. PubMed ID: 2159350
[TBL] [Abstract][Full Text] [Related]
16. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation.
Fitsanakis VA; Au C; Erikson KM; Aschner M
Neurochem Int; 2006; 48(6-7):426-33. PubMed ID: 16513220
[TBL] [Abstract][Full Text] [Related]
17. Altered Gradients of Glutamate and Gamma-Aminobutyric Acid Transcripts in the Cortical Visuospatial Working Memory Network in Schizophrenia.
Hoftman GD; Dienel SJ; Bazmi HH; Zhang Y; Chen K; Lewis DA
Biol Psychiatry; 2018 Apr; 83(8):670-679. PubMed ID: 29357982
[TBL] [Abstract][Full Text] [Related]
18. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
[TBL] [Abstract][Full Text] [Related]
19. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
Takahata R; Moghaddam B
Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiologically based treatment interventions in schizophrenia.
Lewis DA; Gonzalez-Burgos G
Nat Med; 2006 Sep; 12(9):1016-22. PubMed ID: 16960576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
